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Abstract
Background: Thousands of people whose aggression is thought due to serious mental illness are secluded or
restrained every day. Without fair testing these techniques will continue to be used outside of a rigorous evidence
base. With such coercive treatment this leaves all concerned vulnerable to abuse and criticism. This paper presents
the protocol for a randomised trial comparing seclusion with restraints for people with serious mental illnesses.
Methods/Design: Setting-General psychiatric wards of a large psychiatric hospital in Rio de Janeiro, Brazil.
Participants-Anyone aggressive or violent suspected or known to have serious mental illness for whom restriction is
felt to be indicated by nursing and medical staff, but also for whom they are unsure whether seclusion or restraint
would be indicated. Interventions-The standard care of either strong cotton banding to edge of bed with
medications as indicated and close observation or the other standard care of use of a minimally furnished
seclusion room but with open but barred windows onto the nursing station. Outcomes-time to restrictions lifted,
early change of treatment, additional episodes, adverse effects/events, satisfaction with care during episode.
Duration-2 weeks. Identifier: ISRCTN 49454276 http://www.controlled-trials.com/ISRCTN49454276
Background
The association between mental illness and violent beha-
viour has been a controversial topic for public health.
Violence, however, occurs in about 30% of those who
attend psychiatric services for the first time [1]. Violent
or agitated patients present a critical risk to themselves,
to other patients and to staff, so effective, humane and
safe intervention is necessary to prevent injury to every-
one involved [2,3]. After de-escalation techniques have
failed, restraints, seclusion and/or rapid tranquillisation
may be used. Mechanical restraints are often cotton or
leather belts tied to the bedside. Seclusion refers to an
involuntary confinement of a patient in a special room
(locked/unlocked).
Global use of restraints/seclusion
Mechanical restraints are used in many countries; right
across Europe [4-28], the Americas [29-33], the Middle
East [34,35], Central [36-38] and South East Asia [39-41],
Australasia [42-45] and Africa [46,47] (Figure 1). We
have not identified literature describing prevalence of use
of seclusion rooms. Where use of restraints is less preva-
lent [37,48-54] doses of medication tend to be greater
and manhandling common.
Prevalence of use
Survey rates vary (3-50%)[15,25,29,44,55-58], but even the
limited epidemiology suggests that hundreds of thousands
of people with serious mental illness are in restraints every
day. As background for this study we undertook audit of
local practice in Psychiatric Institute Philippe Pinel, Rio
[59]. This audit, combined with high quality evidence
from two proceeding TREC trials [60,61] confirmed that
about 25% of people who are aggressive are physically
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restrained. Subsequent aetiological investigation on the
trial dataset showed that, in Rio, risk factors most strongly
associated with use of restraints were being young, pre-
senting intense agitation more commonly attributed to
substance abuse or diagnoses other than psychosis and
arriving in the morning [62].
Effects and controversy
The safety and clinical effects of mechanical restraints or
seclusion in a psychiatry setting are questionable [63]. A
Cochrane systematic review found no randomised con-
trolled studies [64]. This comprehensive review methodi-
cally searched 12 databases carefully selecting potentially
relevant work. Other authoritative reviews also failed to
identify other means of objective evaluation [2]. Certainly
people are harmed or die in both restraints and seclusion
[3,65] but also if they are not used. In addition to reports
of physical injury and death, qualitative studies illustrate
the negative psychological impact of being restrained
[66,67]. Guidelines encourage minimal use and strict reg-
ulation of restraint/seclusion but, in practice, this may
not occur.
This most coercive part of heath care has avoided any
high grade evaluation and therefore the safety of a very
large most vulnerable group (and their fellow patients as
well as heath care staff) has been neglected.
Setting
Eighty percent of people across the world live in low or
middle income countries and approximately 1-2% of
people suffer from severe mental illnesses [14]. There is
no evidence that psychiatric emergencies are less prevalent
in these countries, therefore, most episodes of aggression
for severely mentally ill people take place in these coun-
tries. The TREC-SAVE study was designed in collabora-
tion with those working in a busy Brazilian psychiatric
care setting to be applicable, at the very least, for everyday
local care Psychiatric Institute Philippe Pinel, in Rio de
Janeiro, Brazil. It provides a service for 25% of a city of
approximately 7 m people and runs a 24 hour psychiatric
emergency room and two acute wards and two longer stay
wards (70 inpatients, 30 emergencies/day). Research into
the evaluation of emergency treatment has been a central
part of the activity of these units since 2003 [39,41,60,61]
and instigation of new procedures for restraint/seclusion
was seen as an opportunity for research once it had been
established that the new procedures were not grounded in
high grade evidence.
We aim to undertake a pragmatic randomized trial to
evaluate, for the first time, the safety, effects and accept-
ability of two widely applicable ways of restricting
aggressive or violent people with serious mental illness;
mechanical restraints compared with use of seclusion
room.
Secondary aims are to illustrate how objective eva-
luative techniques can, carefully, thoughtfully, huma-
nely and ethically be applied to this large, neglected,
part of health care, and to ensure that the means of
evaluation is designed in such a way as to be applic-
able worldwide.
Figure 1 Countries where restraints are used.
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Methods/Design
Size
The aim of TREC-SAVE is to pilot methods, to generate
data relevant for sample size calculations and, if possible,
clinically useful data regarding whether either procedure is
better in terms of clinically measures restriction and per-
ceived treatment success. TREC-SAVE is, in part, a proof
of concept study. Two main factors determine the number
of people who should be recruited to in order for the trial
to provide clear answers. They are the frequency of the
investigated event and the size of the effect of treatment. It
is important to avoid results that are erroneous. The prob-
ability of producing so called ‘false-positive’ results (type I
error-a) and ‘false-negative’ findings (type II error-b) is
minimised by having adequate sample size. However, we
have no data at all from trials even to estimate adequate
sample size [64] and so we recruited ten people as a very
preliminary test of methods and, thereafter, aim to rando-
mise 100 in total. Concerning the primary outcome, 100
patients were needed to give 80% power at a two-sided 5%
significant level to detect a reduction in an assumed value
of 50% to 30% or of 25% to 10%.
Ethical considerations
Trials in non-consenting patients are permitted on two
conditions: i. no other context exists in which to answer
the question; and ii. all trial participants get clear thera-
peutic benefit from whichever arm they are randomised
to. Aggressive patients in a situation of psychiatric emer-
gency are not able to give consent for their participation
in a study. We are not proposing to change routine care.
All treatment will be open and only people for whom
doubt about which care package to give will be eligible.
These are packages of care that are given day to day and
TREC-SAVE simply adds randomisation to situations
where there is clinical doubt and a few additional means
of recording safety and acceptability.
We will obtain informed consent from any accompany-
ing relative (Additional file 1, Appendix 6). If there is no
accompanying relative we do not plan informed consent
at time of randomisation because, by definition, the parti-
cipant lacks capacity. This is full in accordance with The
Helsinki Declaration [68], the European Directive on
Clinical Trials [69], the Nuffield Council on Bioethics
[70] and the US Food and Drugs Administration gui-
dance [71]. Each guidance states that it is possible to
undertake randomisation before gaining consent from
the participant once more recovered or their relative
once accessible. For example, the Helsinki Declaration
reads as follows (section B.29):
“Research involving subjects who are physically or
mentally incapable of giving consent, for example,
unconscious patients, may be done only if the physical
or mental condition that prevents giving informed
consent is a necessary characteristic of the research
population. In such circumstances the physician
should seek informed consent from the legally author-
ized representative. If no such representative is avail-
able and if the research cannot be delayed, the study
may proceed without informed consent provided that
the specific reasons for involving subjects with a condi-
tion that renders them unable to give informed con-
sent have been stated in the research protocol and the
study has been approved by a research ethics commit-
tee. Consent to remain in the research should be
obtained as soon as possible from the subject or a leg-
ally authorized representative.”
This is a project that has to have the most careful
ethical considerations. Current clinical practice on vul-
nerable [if aggressive] people who are given coercive
treatment is necessary but, if carefully considered in the
light of the complete lack of research in the area, may
be considered barely ethical in itself. The treatment, in
the context of a randomised trial tailored to the needs
of the services and patient, is, we argue, highly ethical.
We have the exacting scrutiny and then support of local
Psychiatric Institute Philippe Pinel Ethics Committee
which has a track record in protecting the rights of all
participants.
TREC-SAVE is designed to fit into everyday practice
The great majority of clinical trials are explanatory; they
are small, short, evaluate rigid care regimens, measure
outcomes in ways that are of little clinical value and are
difficult to relate to everyday practice [72]. Pragmatic
trials, on the other hand, evaluate care that can be used
in everyday practice and measure outcomes that are of
general concern. This is a pragmatic randomised trial,
designed with and for staff and policy makers of Psy-
chiatric Institute Philippe Pinel, Rio de Janeiro, Brazil.
Randomisation
A fundamental step in such a trial is the randomisation;
the distribution of the treatments in a way that is not a
function of a clinical decision, but of pure chance. Ran-
domisation will be undertaken in Brazil, blocks of 4 and
6 in random order, within which randomly generated
sequences of treatments were generated using the “List
Randomizer” option from http://www.random.org/
inputting blocks of 4 and 6 numbers. The sequence for
inputting the blocks of 4 or 6 itself being established at
random. Allocation will be fully concealed and underta-
ken by personnel not involved in the clinical interface.
Consecutively numbered sealed, fully opaque envelopes,
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identical in every way to the outside observer will be pre-
pared and each will contain the information regarding
trial conduct and directions to either seclude or restrain
as per normal care. These envelopes are held in TREC-
SAVE boxes on the wards and their order of opening will
be checked by the trial researcher.
TREC-SAVE is blinded for the initial ratings only
It is impossible to blind people to seclusion or restraint,
but, in any case, because TREC-SAVE evaluates care in
the emergency situation, it is imperative that the doctors
and nurses know which intervention is being given.
Also, we wish to evaluate the open giving of an approach
as would happen in everyday care. Full blinding is,
therefore, not desirable. The study, however, is blind up
until the time that the TREC-SAVE envelope is opened.
Therefore, it is crucial that the evaluation of the severity
of a person’s disturbance and the first impression on the
possible cause for the disturbed behaviour are recorded
before this envelope is opened (Figure 2).
Participants
Aggressive/violent mentally ill people admitted to Psy-
chiatric Institute Philippe Pinel, in Rio de Janeiro, Brazil.
Inclusion criteria
- Anyone thought to have a serious mental illness
admitted to the hospital who has a degree or risk of
aggression or violent behaviour that endangers
themselves or others; and
- Who is thought by medical and nursing staff to
need some form of physical restriction; and
- For whom the medical and nursing staff have
doubt as to whether one form of restriction is better
than the other.
Exclusion criteria
- Anyone for whom either or both packages of care
are contraindicated by either medical or nursing
staff; or
- Anyone already randomised in this trial.
Recruitment
According to local audit Psychiatric Institute Philippe
Pinel, covers an area that refers to about 600,000 people,
and has 90 inpatients every day and sees about 50 peo-
ple in the emergency rooms. Ten percent of this group
are agitated and one quarter need some restraints but
we are unclear about what proportion of this group the
health care staff have some doubt about whether to use
one form of restraint or another. We estimate this to be
one in 10 people and therefore it is likely that recruit-
ment will be around 2 persons per week.
Interventions
1. Use of four point physical restraint (cotton bands)
and policy of close recording of mental state, behaviour,
wellbeing, in addition to standard use of medication.
2. Use of secure seclusion room and policy of close
recording of mental state, behaviour, wellbeing, in addi-
tion to standard use of medication.
In the case of Psychiatric Institute Philippe Pinel
secure seclusion involves a locked room with minimal
bedding but bright and airy with good day light though
barred windows with no frame or glass open to the nur-
sing station. There is a simple toilet and sink. The
standpoint of care is that both care packages are under-
taken wishing the least restriction for the least period of
time. The Directorship of the Institution is wishing to
increase safety, monitoring and yet decrease restriction
of patients and is supportive of this work to ensure that
new policies are based on good evidence.
Procedures
For all eligible patients the administering nursing staff
will confirm that they feel that the clinical state of the
potential participant still meets eligibility and, if so, take
the next sealed envelope in a pre-prepared pack. If they
feel that the potential participant does not meet eligibil-
ity they will not randomise and proceed with normal
clinical care. If possible data on those not entering the
study but in need of restraint or seclusion will be
recorded (Additional file 1, Appendix 3).
Before opening the envelope the nurse will fill out a
Clinical Global Impression [73] regarding the degree of
danger and aggression (Additional file 1, Appendix 1,
Formulário 1). Inside the envelope will be the allocation
to use of restraints, or seclusion and a sticker. The latter
will be pasted on the patient’s notes to alert staff that this
person has been part of the study (and also should not be
randomised again). The envelope will be discarded into a
specific container. Clinical data will then be recorded
(Additional file 1, Appendix 1, Formulário 2). This
involves the careful recording of the reasons for seclu-
sion, half hourly monitoring of mental state and well-
being by nursing staff, hourly monitoring by medical staff
and recording of any adverse event or effect as well as
the duration of the restriction. At any time the medical
or nursing staff will be free to change treatment options.
Serious events
After trial entry, clinical events are recorded, as usual, in
the patients’ notes. Complications and adverse events
should be managed as usual. A serious unexpected
event form (Additional file 1, Appendix 1, Formulário 3)
is provided, and will be sent to the TREC-SAVE Co-
ordinator as soon it is completed.
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Outcomes
Safe resolution of episode, time in restriction, further
episode, amount of medication (in 24 h) and how admi-
nistered, acceptability to patient/staff, adverse effects-fol-
low up 2 weeks or to discharge if before 2 weeks.
Primary outcomes, requested by the nursing and med-
ical staff of the hospital, are release from restraints or
seclusion by 4 hours, and usefulness of allocated treat-
ment as measured by the need or not to change treat-








Figure 2 TREC-SAVE CONSORT diagram.
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Patients will be followed for 24 hours after the end of
the restriction but routinely collected data on use of
medications and further episodes for up to 14 days or
until discharge if before. Right after the end of the
restriction relevant staff will be asked if they feel the
episode was, within the care package, managed satisfac-
torily and asked to rate this on a simple visual analogue
scale. Also, and again right after the end of episode of
the restriction, the participant will be asked to rate their
satisfaction with the management of the relevant epi-
sode and again on simple visual analogue scale.
Other relevant outcomes are: refusal to take oral med-
ication, other episode of restraint/seclusion, need to see
the doctor again (Additional file 1, Appendix 8).
Data collection, entry and analysis
All analysis will be based on groups as randomly allo-
cated; this will be an intention-to-treat analysis. Relative
risk, risk difference, number needed to treat and respec-
tive 95% confidence intervals will be estimated and for
continuous outcomes mean difference will be assessed
(Additional file 1, Appendix 8).
Trial organisation
The TREC-Rio Co-ordinating Group: The co-ordinating
centre of the Rio de Janeiro arm is based at Oswaldo Cruz
Foundation, Rio de Janeiro, Brazil. The Co-ordinating
Group has overall responsibility for the design of the study
and is responsible for all aspects of day to day trial admin-
istration. The Co-ordinating team is also responsible for
preparing reports for the steering committee. Member-
ship: Gisele Huf, Evandro SF Coutinho, Clive Adams.
The TREC-Rio Steering Committee: The overall pro-
gress of the trial, adherence to protocol, patient safety and
the consideration of new information will be monitored by
a scientific and administrative steering committee. At the
end of the proposed study period, the Steering Committee
will consider the extension of the study, to allow the
detection of other important effects. The membership of
this committee is: Evandro S.F. Coutinho (Chair), Gisele
Huf, Clive E. Adams, Marco A. V. Ferreira, José Lincoln
Souza Cruz, Fernando Ramos and Silvana Ferreira.
Data monitoring
Should recruitment to TREC-SAVE be slow (take more
than one year) or very swift (more than 100 in the
expected six month recruitment period), an independent
data monitoring committee (DMC) will, in confidence,
monitor results. Should recruitment to the TREC-SAVE
be slow or go beyond 100, interim results will be supplied,
in strict confidence to the chair of DMC or as frequently
as requested. Meetings of the committee will be arranged
periodically as considered appropriate by the chair of the
committee. In the light of the interim data, and of any
other evidence or advice they wish to seek, the DMC will
inform the chair of the steering committee if, in their
view: i. there is proof beyond reasonable doubt that for
any particular group or subgroup treatment with one or
other regiment is clearly indicated or contraindicated or:
ii. it is evident that no clear outcome will be obtained.
Proof beyond reasonable doubt may be taken as the differ-
ence of at least three standard deviations and at least one
of the primary outcomes.
The DMC may communicate certain interim analysis
to the steering committee or suggest certain protocol
changes, but the steering committee will remain respon-
sible for deciding which changes to adopt. The member-
ship of this committee is: Claudio Jose Struchiner
(chair), Luiz Antonio Bastos Camacho and Jose Ramón
Rodrigues Arras Lopez.
Funding
No participating centre will directly receive funds for
involvement in TREC-Rio. By design, funding for the
overall project is minimal. All funding is intramural and
everyone involved is undertaking this project as part of
their usual funded employment. This support is jointly
funded by National Institute of Quality Control in
Health-Oswaldo Cruz Foundation, Cochrane Schizophre-
nia Group, and Federal University of Rio de Janeiro.
Proposed policy for publication and authorship
Because this area of health care has been so long neglected
but is, nevertheless, part of everyday care across the globe,
and because the interventions to be studied are inexpen-
sive clinical techniques rather than inaccessible treat-
ments, the impact of this work is likely to be high.
Part of the publication plan is preliminary work already
undertaken in preparation for this application on a local
survey of the practice of use of restraints for aggressive
people with serious mental illness. This has been ana-
lysed and published [59]. Full results will be published
and disseminated in a variety of fora including academic
meetings, the internet and journals. Efforts will also be
made to disseminate findings in a usable form though
patient advocate group. The Cochrane review will be
updated. There will be a collective authorship (the
TREC-SAVE Collaborative Team) but also named
authors representing that group as for this paper.
Future research
We are aware that this study will be ground breaking.
There are none to precede it. We expect that much will be
learnt in how to conduct such a study and the strengths
and weaknesses of our simple design. The trial runs well
this design can form a template for others. If numerical
results are not informative we will have some idea of the
power needed for the larger study if we can identify a
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source of support. Even if the numerical findings were to
be clinically meaningful for Rio de Janeiro indiscriminate
generalising of the results of such a small trial would not
be prudent. Replication will be necessary both locally and
in other settings.
Additional material
Additional file 1: All forms used in the study and dummy outcome
tables. This file contains 8 Appendices. Appendix 1. Forms in Portuguese.
Appendix 2. Data transcription forms-translated to English. Appendix 3.
Forms for data for those not entering study. Appendix 4. Forms for
additional episodes. Appendix 5. Impression of how episode was
perceived. Appendix 6. Informed consent-from accompanying relative.
Appendix 7. Poster for wards. Appendix 8. Dummy tables.
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